Blind interim in parallel design? [Two-Stage / GS Designs]

posted by Astea – Russia, 2019-06-03 01:47  – Posting: # 20312
Views: 1,074

Dear Helmut!

» I don’t get your subject line. Do you mean that...

I am very sorry for confusing! (neither of them, but I really love your way of thinking!!) It has to mean "Blind men and an elephant", a parable about how difficult is to find the truth if you have only limited data :pirate:. That was about parallel blind studies.

» Simulations… Might be tricky cause we have to think about unequal group sizes and/or variances.

As far as I understood from an article by A. Fuglsang*, heteroscedasticity should not cause problems. But for blind studies CVaverage (that is not distinguishing treatments) is not equal to CVpooled, how to deal with it? Is there a way to prove a possibility of inflation in blind parallel studies?

Complete thread:

 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
19,545 posts in 4,145 threads, 1,340 registered users;
online 10 (0 registered, 10 guests [including 4 identified bots]).
Forum time (Europe/Vienna): 11:31 CEST

Anyone who has never made a mistake
has never tried anything new.    Albert Einstein

BEBAC Ing. Helmut Schütz